Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-02-12 | 2021-02-12 |
| Drug Identification Number | 02287633 | 02287633 |
| Brand name | CEFTRIAXONE SODIUM FOR INJECTION | CEFTRIAXONE SODIUM FOR INJECTION |
| Common or Proper name | CEFTRIAXONE SODIUM INJ 1GM | CEFTRIAXONE SODIUM INJ 1GM |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | CEFTRIAXONE | CEFTRIAXONE |
| Strength(s) | 1G | 1G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10pk | 10pk |
| ATC code | J01DD | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2021-01-06 | 2021-01-06 |
| Estimated end date | ||
| Actual end date | 2021-02-05 | 2021-02-05 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | This item is discontinued | This item is discontinued |
| Health Canada comments |